胰腺癌细胞的增殖同膜脂质饱和度,膜胰岛素受体的关系

外源性表皮生长因子(或生长抑素)能促进(或抑制)胰腺癌细胞的增殖。胰腺癌细胞增殖速率的高低与细胞膜脂质饱和度的降、升;与膜胰岛素受体数量的增减密切相关。测定细胞膜脂质饱和度和胰岛素受体数量,是判断胰腺癌增殖状态的灵敏指标,有一定临床价值。     

Pulsatility and resistance indices in intrarenal arteries of normal adults

In order to establish the normal range of values of Pulsatility (PI) and Resistance (RI) Indices in the intrarenal vasculature, a study of 50 healthy volunteers (23 males, 27 females), divided into five groups of 10 according to age, was performed with Duplex Doppler ultrasound. Both kidneys were examined in all individuals and, in 12, indices were also compared between upper and lower poles of both kidneys. In addition, repeat examinations were performed in nine subjects on three different days, in order to assess the reproducibility of the method. No differences were found in the mean values of both indices between males and females, upper and lower poles, right and left kidneys. A statistically significant increase (p < 0.01, unpaired t-test) was demonstrated when the oldest age group (7th decade) was compared to the youngest age group (3rd decade). The method appeared remarkably reproducible for RI (4.2–7%), with wider variation in the PI (9.5–22.7%).     

How can we predict ureteral obstruction after gynecological surgery? The changes in Doppler resistive index and plasma creatinine and magnesium concentrations after surgical, unilateral ureteral obstruction in a rabbit model

The aim of this study is to evaluate the changes in Doppler resistive index (RI) and plasma creatinine and magnesium concentrations after unilateral ureteral obstruction in a rabbit model. Fourteen adult female rabbits were used in this study. In seven rabbits, the left ureter was ligated with silk suture, and the control group was sham operated. Before surgery and on the second and seventh days after surgery, blood samples were obtained to measure plasma creatinine and magnesium concentrations. Doppler RIs of both kidneys were also measured before surgery and on the second and seventh days after the surgical procedure. With regard to magnesium levels, there was a significant within-subjects sessions difference [F(2, 20) = 15.21, P= 0.001] indicating a decrease through sessions. Magnesium concentrations decreased significantly at the postoperative second and seventh days compared to preoperative baseline levels (P= 0.003 and P= 0.001, respectively). Multifactorial analysis of variance was applied for each session separately with laterality, and groups as factors. The Doppler RI and the creatinine level did not show any significant differences or interactions for all sessions (P > 0.05). The decreasing plasma magnesium concentration after surgery may indicate ureteral injury; however, Doppler studies and creatinine levels may not be useful as well.     

玉溪市农村室内鼠类及其体外寄生蚤类调查

笔者于１９９２年２月至１９９３年１月，在玉溪市两个自然村室内进行了鼠类及体外寄生蚤类调查研究。鼠类年均捕获率７．２５％；褐家鼠为优势种，占７３．４９％，捕获率高峰期在９月；黄胸鼠和小家鼠为常见种，捕获率高峰期分别在３和４月。３种家鼠年龄孕鼠率为１４．５７％，平均胎仔数为７．３只，１０月为全年生殖高峰。     

A -243A-->G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects.

AIMS: The glutamate decarboxylase gene (GAD2) encodes GAD65, an enzyme catalysing the production of the gamma-aminobutyric acid (GABA) which interacts with neuropeptide Y to stimulate food intake. It has been suggested that in pancreatic islets, GABA serves as a functional regulator of pancreatic hormone release. Conflicting results have been reported concerning the potential impact of GAD2 variation on estimates of energy metabolism. The aim of this study was to elucidate potential associations between the GAD2-243A-->G polymorphism and levels of body mass index (BMI) and estimates of glycaemia. METHODS: Using high-throughput chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, the GAD2-243A-->G (rs2236418) polymorphism was genotyped in a population-based sample (Inter99) of 5857 middle-aged, unrelated Danish White subjects. RESULTS: The G-allele was associated with modestly lower BMI (P = 0.01). In a case-control study of obesity, the G-allele frequency in 2582 participants with BMI < 25 kg/m2 was 19.5% (18.4-20.6) compared with 17.1% (15.5-18.8) in 968 participants having BMI > or = 30 kg/m2 (P = 0.03), odds ratio 0.9 (0.7-1.0). Of the 5857 subjects, GG carriers had lower fasting plasma glucose levels (mmol/l) [AA (n = 3859) 5.6 +/- 0.8; AG (n = 1792) 5.5 +/- 0.8; GG (n = 206) 5.5 +/- 0.8, P = 0.008] and lower 30-min oral glucose tolerance test (OGTT)-related plasma glucose levels (AA 8.7 +/- 1.9; AG 8.6 +/- 1.9; GG 8.6 +/- 2.0, P = 0.04), adjusted for sex, age and BMI. Analysing subjects who were both normoglycaemic and glucose tolerant (n = 4431) GG carriers still had lower fasting plasma glucose concentrations: AA (n = 2895) 5.3 +/- 0.4; AG (n = 1383) 5.3 +/- 0.4; GG (n = 153) 5.2 +/- 0.4 (P = 9.10(-5)). CONCLUSION: The present study suggests that the GAD2-243A-->G polymorphism in a population of middle-aged White people associates with a modest reduction in BMI and fasting and OGTT-related plasma glucose levels.     

精子形态变化对体外受精率的影响

目的:通过对ICSI和IVF受精率的统计,比较精子形态中的精子正常形态率、头部畸形率、畸形精子指数(TZI)和精子畸形指数(SDI)对受精结果的影响。方法:用Krger's严格标准法分别计算每组样本的精子正常形态率、头部畸形率、TZI和SDI值,与受精率进行比较。结果:①IVF组和ICSI组的受精率,与精子正常形态率、头部畸形率、TZI、SDI均无相关性。②IVF组和ICSI组中SDI>1.6和SDI<1.6的受精率、优质胚胎率和临床妊娠率差异均无统计学意义(P>0.05)。③IVF组和ICSI组中精子正常形态率≤15%与精子正常形态率>15%的二组间受精率、优质胚胎率和临床妊娠率的差异均无统计学意义(P>0.05)。结论:精子形态在体外受精时对受精率无影响,不能用精子形态来直接评价体外受精的结果。     

大脑中动脉钙化的CT与经颅多普勒超声对照研究

目的探讨大脑中动脉（middle cerebral artery,MCA）水平段（M1）钙化的量化指标与血流动力学的关系。资料与方法搜集经头颅CT确诊M1段钙化且行经颅多普勒超声（transcranial Doppler,TCD）检查者41例,按有无钙化分为钙化组和无钙化组。分析MCA钙化组血流动力学参数与钙化量化指标是否有相关性;检验钙化组与无钙化组血流动力学参数及狭窄发生率的差异。结果MCA搏动指数（pulsatility index,PI）与钙化体积以及积分值呈线性相关;钙化组与无钙化组PI差异有统计学意义（P〈0.05）,但狭窄发生率差异无统计学意义（P〉0.05）。结论MCA钙化程度与TCD反映血管弹性的PI相关,但与反映狭窄程度的血流速度无相关性。     

老年冠心病患者踝臂指数和心脏结构与功能的相关分析

目的探讨老年冠心病患者踝臂指数(ABI)和心脏结构与功能的相关性。方法87例老年冠心病患者,按ABI分组,A组ABI≤0.9,B组ABI>0.9,同时测量2组的心脏结构指标:左心房直径(LAD)、左心室舒张期直径(LVDD)、左心室后壁厚度(LVPW)。左室收缩功能指标:左室缩短率(FS)、左室射血分数(EF)。左室舒张功能指标:EF斜率。结果A、B2组比较,年龄、血脂、血糖、肝功能、肾功能、LAD、LVDD、LVPW和EF斜率均无显著性差异。FS和EF均有显著性差异,A组较B组明显降低(P<0.05)。结论ABI与老年冠心病患者的心脏功能有较好的相关性,对其预后的判定有一定的价值。     

放射性核素阴囊血池显像技术诊断精索静脉曲张的临床研究

目的:探讨放射性核素阴囊血池显像(RSI)技术诊断精索静脉曲张(VC)的价值。方法:本组126例有男性不育1年以上病史、精液分析异常的患者分别接受临床体格检查(PE);RSI技术检查,计算两侧阴囊血池指数值(SBPI),并观察是否有精索静脉血液返流;以及彩色双功能多普勒显像(CDFI)检查,对VC进行分型、定度。将PE,RSI结果分别与CDFI结果对比。结果:PE、RSI诊断VC的灵敏度分别为:71.7%、96.5%,特异度分别为:69.1%、97.1%。RSI诊断VC的灵敏度、特异度均高于PE。结论:RSI技术是诊断临床型、亚临床型VC的简单、安全、有效的无创诊断方法,也是一种非侵袭性,更加客观、准确地诊断VC的有效方法。     

A method for assessing quality of control from glucose profiles.

AIM: As the practice of multiple assessments of glucose concentration throughout the day increases for people with diabetes, there is a need for an assessment of glycaemic control weighted for the clinical risks of both hypoglycaemia and hyperglycaemia. METHODS: We have developed a methodology to report the degree of risk which a glycaemic profile represents. Fifty diabetes professionals assigned risk values to a range of 40 blood glucose concentrations. Their responses were summarised and a generic function of glycaemic risk was derived. This function was applied to patient glucose profiles to generate an integrated risk score termed the Glycaemic Risk Assessment Diabetes Equation (GRADE). The GRADE score was then reported by use of the mean value and the relative percent contribution to the weighted risk score from the hypoglycaemic, euglycaemic, hyperglycaemic range, respectively, e.g. GRADE (hypoglycaemia%, euglycaemia%, hyperglycaemia%). RESULTS: The GRADE scores of indicative glucose profiles were as follows: continuous glucose monitoring profile non-diabetic subjects GRADE = 1.1, Type 1 diabetes continuous glucose monitoring GRADE = 8.09 (20%, 8%, 72%), Type 2 diabetes home blood glucose monitoring GRADE = 9.97 (2%, 7%, 91%). CONCLUSIONS: The GRADE score of a glucose profile summarises the degree of risk associated with a glucose profile. Values < 5 correspond to euglycaemia. The GRADE score is simple to generate from any blood glucose profile and can be used as an adjunct to HbA1c to report the degree of risk associated with glycaemic variability.